Ichinose Junji, Suzuki Ayumi, Matsuura Yosuke, Nakao Masayuki, Okumura Sakae, Ninomiya Hironori, Mun Mingyon
Department of Thoracic Surgical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
Department of Pathology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
J Thorac Dis. 2024 Sep 30;16(9):5958-5968. doi: 10.21037/jtd-24-944. Epub 2024 Sep 12.
The appropriate extent of hilar lymph node (LN) dissection in segmentectomy for lung cancer has not yet been fully investigated. Herein, we assessed the patterns of LN metastasis using network analyses.
Patients with nodal metastases of non-small-cell lung cancer measuring ≤30 mm in diameter who underwent anatomical resection were included. The assumed pathways of metastasis were visualized using Cytoscape software. Metastasis to hilar (#10) or interlobar (#11) LNs but not to more peripheral ones was defined as skip N1 metastasis.
A total of 322 patients were included, with 123 of them having pleural invasive tumors and 32 having intrapulmonary metastases. There were 130 patients with pN1 disease and 192 with pN2 disease. The overall proportion of patients with skip N1 metastasis was 17%. Patients with lower lobe tumors had more frequent skip N1 metastasis than those with upper lobe tumors (31% 10%, P<0.001) but had less frequent skip N2 metastasis (10% 20%, P=0.02). The rates of skip metastasis to #11i in the right S6 tumor and right S9-10 tumor were unexpectedly high (22% and 17%, respectively). Similarly, skip metastasis to #11 in the left S6 tumor was relatively high (16%). There was a significant difference in the frequency of skip LN metastasis between tumors with and without pleural invasion (44% 27%, P=0.001).
The pattern of LN metastasis differed according to the localized segment of the tumor and the pleural invasion status.
肺癌肺段切除术中肺门淋巴结清扫的合适范围尚未得到充分研究。在此,我们使用网络分析评估了淋巴结转移模式。
纳入接受解剖性切除、直径≤30mm的非小细胞肺癌淋巴结转移患者。使用Cytoscape软件可视化假定的转移途径。转移至肺门(#10)或叶间(#11)淋巴结但未转移至更外周淋巴结被定义为跳跃性N1转移。
共纳入322例患者,其中123例有胸膜侵犯性肿瘤,32例有肺内转移。有130例pN1疾病患者和192例pN2疾病患者。跳跃性N1转移患者的总体比例为17%。下叶肿瘤患者的跳跃性N1转移比上叶肿瘤患者更常见(31%对10%,P<0.001),但跳跃性N2转移较少见(10%对20%,P=0.02)。右S6肿瘤和右S9-10肿瘤跳跃转移至#11i的发生率意外地高(分别为22%和17%)。同样,左S6肿瘤跳跃转移至#11的发生率相对较高(16%)。有和无胸膜侵犯的肿瘤之间跳跃性淋巴结转移频率有显著差异(44%对27%,P=0.001)。
淋巴结转移模式因肿瘤的局部节段和胸膜侵犯状态而异。